Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer.

Luc Y DirixAndy BuysSteffy OeyenDieter PeetersVincent LiègeoisAnnemie ProvéDieter RondasLiesbet VervoortVéronique MariënSteven Van LaerePeter Vermeulen

Published in: Breast cancer research and treatment (2022)

Our data demonstrate the analytical and prognostic equivalence of CellSearch and RareCyte CTC enumeration platforms in patients with MBC using the CellSearch cut-off. This is the first demonstration of prognostic significance using the RareCyte platform.

Keyphrases

circulating tumor
circulating tumor cells
metastatic breast cancer
cell free
multiple sclerosis
single cell
cell therapy
electronic health record
high throughput
big data
stem cells
liquid chromatography
real time pcr
machine learning
quantum dots